Annual report pursuant to Section 13 and 15(d)

Stockholders??? (Deficit) (Details Narrative)

v3.22.1
Stockholders’ (Deficit) (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
May 15, 2021
May 13, 2021
Jul. 21, 2021
Jul. 19, 2021
May 18, 2021
Dec. 31, 2021
Dec. 31, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Capital stock authorized           260,000,000  
Common stock, authorized           250,000,000 250,000,000
Common stock, par value   $ 0.001 $ 0.001     $ 0.001 $ 0.001
Preferred stock, authorized           10,000,000 10,000,000
Preferred Stock, Par or Stated Value Per Share           $ 0.001 $ 0.001
Aggregate of shares   1,600,000 1,375,000        
Exercise price   $ 7.425 $ 6.15        
Offering price   $ 6.75          
Underwriters agreed to purchase   $ 1,600,000 $ 1,031,250        
Discount rate   7.50%          
Purchase additional shares 240,000 240,000          
Additional warrants $ 240,000 $ 240,000          
Gross proceeds $ 9,500,000   $ 8,305,000 $ 50,000      
Cash fee       6.50%      
Stock option exercise           6,592  
Proceeds from common stock shares received           $ 3,381,271  
Share-based compensation expense for options           171,798 $ 158,728
Total unrecognized compensation expense           $ 432,296  
Weighted average period expected to recognized compensation expense (in years)           2 years 7 months 28 days  
Series A Preferred Stock Dividend Rate           10.00%  
Conversion of Stock, Shares Converted         1,401,786    
Accured unpaid dividends           $ 1,179,357  
Accrued dividends           $ 0 $ 1,115,674
Warrant [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Stock option exercise           455,390  
Stock option exercise           455,390  
Common Stock [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Stock option exercise           5,060 2,500